Position in ZTS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,178,504
-$2,844,773 QoQ
Shares Held
16,400
-51.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#599
of 1,408 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Voleon Capital Management LP holds $25,492,821 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #8 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
|
486,052 | $8,413,560 | |
| 2 | VTRS |
Viatris Inc
|
289,259 | $4,593,432 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
7,649 | $4,144,457 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
32,806 | $2,097,943 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
204,732 | $1,621,477 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
31,138 | $1,471,893 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
132,206 | $1,322,060 | |
| 8 | ZTS |
Zoetis Inc.
This page
|
16,400 | $1,178,504 |
All Filings in ZTS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,178,504 | 16,400 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,023,277 | 34,035 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,928,187 | 70,960 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,876,499 | 122,174 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,268,264 | 59,431 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,380,933 | 56,975 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $2,609,486 | 16,016 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||